Commentary · 24 Feb 2026
Conference abstractPublished 1 Dec 2016
Recent treatments for cardiac arrhythmias: Confusion of ganglionated plexi (GP), fibrosis and myocardial structural diseases areas, leading to similarity of detected signals (complex atrial fractionated electrograms)
Ottawa University, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Atrial Fibrillation (AF) is a major life threatening disease which is still refractory to all pharmaceutical compounds. Catheter ablation procedure is currently used as an âÂ?Â?easy and safeâÂ?Â? clinical intervention targeting the early activation sites that are triggering the initiation of arrhythmias. However, the catheter ablation procedure is still considered as ineffective treatment for long-term curing of arrhythmias and for preventing their recurrences. Despite the high technologies for mapping, detecting and delivering the right energy sources to any location in the human cardiac heart chambers insulating the right triggers areas for AF still the main challenges to all currently existing devices companies (ex. Biosense Webster (subsidiary of J&J; Carto Solution), St Jude Medical Inc, (Ensite system), Boston Scientific, Medtronic (with Cryocath Technologies, Atricure Inc, etc). Detecting the sites of early activations and the locations of the triggers ganglia are still confused with other structural diseases such as fibrosis, which are limiting those devices to achieve the detection of the right hit (ex. triggering GP). Thus, it adds complications and risks to the long-term inefficacy of the catheter ablation procedure, in addition to major side effects and complications to this minimally invasive clinical procedure. âÂ?Â?NerveCâÂ?Â? is developing a high end assembly able to detect selectively the GPlocations. Thus, it will limit the confusion during mapping of the heart for electrophysiological (EP) study and for catheter ablation procedure for offering long-term cure from cardiac arrhythmias, such as atrial fibrillation, a major disease that affects our aging population. Therefore, by introducing âÂ?Â?NerveCâÂ?Â? to the EP clinical practice will help to detect selective EP signals generated by the autonomic nerve (=GP) using the FFT (Fast Fourier Transformation), offering a unique method to specifically targeting the rotors triggering the cardiac AF.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Neurological Disorders.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalNeurological Disorders
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Marc Mounir Rahme”
